Certara
在场
高管
查看带有其 25 名主要高管的组织结构图
Certara 搜索最多的简介
- William Feehery, Chief Executive Officer and Director
- Stephen McLean, Director
- David Spaight, Director
高管在Certara变化
- Adrian Mckemey已作为President of Drug Development Solutions加入公司 (新闻发布的2025三月7号).
- John Reynders已作为Independent Board Member加入公司 (新闻发布的2024十月18号).
创建提醒
跟踪 Certara 的高管变动
药店
Certara 拥有 1,833 家竞争者，其中包括 Pfizer (美国(美洲))、Roche (瑞士) 和 Sanofi (法国)。
Popular M&A news in 药店
- Clario 已收购 NRx Pharmaceuticals (公布2025三月18号).
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
药店 行业的其他推荐联系人
消息
Certara 的最新新闻稿
- News
- Certara Reports Fourth Quarter 2024 Financial Results
- Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
- Certara Showcases 2024 Research Wins with Over 100 Papers Published
- Certara Reports Third Quarter 2024 Financial Results
- Certara Appoints John Reynders as New Independent Board Member
- Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
- Certara Completes Acquisition of Chemaxon
- Certara’s Simcyp Consortium Celebrates 25th Anniversary
- Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
- View more press releases Close
